Cell Therapy Manufacturing and the Unique Requirements for a LIMS, QMS, and MES Solution

The manufacturing and delivery of cell therapies share similar attributes of processing which distinguishes them from pharmaceutical or biopharmaceutical products. They require end-to-end visibility that ensures chain of custody, identity, and condition.

This impacts various aspects of the process including the quality management, LIMS and MES solutions leveraged in these organizations. In this blog we discuss the unique requirements.  [Read More]

Please to read the entire article.